E10-01: Anemia

Robert Pirker
2007 Journal of Thoracic Oncology  
References [1] Papotti M, Kalebic T, Volante M, et al. Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study. J Clin Oncol 2006;24:4818-24. [2] Bepler G. Pharmacogenomics: a reality or still a promise? Lung Cancer 2006;54(Suppl 2):S3-7. [3] Danesi R, De Braud F, Fogli S, et al. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer. Pharmacol Rev 2003;55:57-103. [4] Ceppi P, Volante M, Novello S, et
more » ... te M, Novello S, et al. ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Ann Oncol 2006;17:1818-25. [5] Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006;355:983-91. [6] Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in earlystage non-small-cell lung cancer. N Engl J Med 2006;355:570-80.
doi:10.1097/01.jto.0000283021.57014.94 fatcat:eayccvxewbe5jiewbniqemxafu